Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

ERN-RITA/PReS recommendations for the diagnosis, classification, monitoring, and treatment of childhood idiopathic (primary) angiitis of the central nervous system.

Created on 13 Nov 2026

Authors

Tamás Constantin, Kata Takács, Brian Feldman, Zoi Anastasa, Jordi Anton, Stefan Berg, Malene Landbo Børresen, Roberta Caorsi, Marco Cattalini, Monika Csóka, Sarolta Dobner, Perrine Dusser, Silvia Federici, Marco Gattorno, Mónika Gellért, Marta Gómez-Chiari, Sandra Hansmann, Cheryl Hemingway, Zsuzsanna Horváth, Marija Jelušić, Isabelle Koné-Paut, Ming Lim, Kshitij Mankad, Sándor Nardai, Ekemini A Ogbu, Seza Ozen, Angelo Ravelli, Gabriele Simonini, Attila Szabó, Márton Szabados, Jaroslaw Smiechowicz, Marinka Twilt, Hanga Vecserka, Jelena Vojinović, Peter Weiser, Ronny Wickström, Mojca Zajc Avramovič, Paul Brogan, Susanne M Benseler

Published in

Annals of the rheumatic diseases. Nov 12, 2026. Epub Nov 12, 2026.

Abstract

Childhood central nervous system (CNS) vasculitis is a rare and serious disease for which no evidence-based consensus guidance, standardised terminology, or definitions of treatment response exist. We aimed to develop the first international recommendations for the diagnosis, classification, monitoring, and treatment of CNS vasculitis in children.
Adapting the European Alliance of Associations for Rheumatology standardised operating procedures, an international multidisciplinary panel of 42 experts from 15 countries was assembled through the European Reference Network on Rare Immunodeficiency, Autoinflammatory, Autoimmune and Paediatric Rheumatic Diseases, and the Paediatric Rheumatology European Society. A systematic literature review across 4 databases identified 182 eligible studies, graded per the Oxford Centre for Evidence-Based Medicine hierarchy. A modified Delphi survey (42 respondents) was followed by a 2-day face-to-face consensus conference (26 voting members; ≥70% agreement required).
The panel formulated 83 consensus statements (3 overarching principles, 14 principles, and 66 recommendations) across 7 clinical domains. Of 182 included articles, 152 (83.5%) reported paediatric data; no level 1 evidence was identified. Key advances include an 8-domain nomenclature system replacing the 'primary/secondary' dichotomy with 'idiopathic/disease-associated' terminology, a paediatric-specific vessel wall imaging interpretive principle, a prospective risk-stratification model for disease progression, genome-wide sequencing as the preferred genetic testing approach, and formal definitions of remission, relapse, and refractory disease. None of these elements had been previously codified for childhood CNS vasculitis.
These recommendations establish a comprehensive, evidence-graded framework for childhood CNS vasculitis. The absence of level 1 evidence across all domains points to the need for an international prospective registry and collaborative clinical trials.

PMID:
43020703
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement